Navigation Links
Cancer theory stands the test of time -- rediscovering Boveri a century later
Date:2/29/2008

COLD SPRING HARBOR, N.Y. Rarely has a book in the biological sciences proved as prescient as Theodor Boveris 1914 monograph Concerning the Origin of Malignant Tumours. Out of print for decades and previously almost impossible to track down, the book is now available as a new and authoritative translation, co-published by Cold Spring Harbor Laboratory Press and The Company of Biologists.

Concerning the Origin of Malignant Tumours had a huge impact on cancer research. In it, Boveri was the first to argue that cancer is caused by defects in chromosomes and that these can be caused by a failure of cells to divide properly. He also proposed that the cells natural urge is to divide and that it is held in check by specific mechanisms that prevent cancer almost a hundred years later we know this to be true, having identified so-called tumor suppressors like the retinoblastoma protein. Perhaps most astonishingly, Boveri also predicted the existence of genes, suggesting that hereditary characters are aligned along chromosomes in a specific order.

Regularly quoted and frequently misquoted the only English version of Concerning the Origin of Malignant Tumours ever available before was a rare translation by Boveris wife, who was not a biologist. The new translation is by Sir Henry Harris, Regius Professor of Medicine at Oxford University, and includes extensive annotations in which Harris discusses the relevance of Boveris views today.

Reviewing the book, leading geneticist Felix Mitelman wrote that he cannot find superlatives enough to praise the lucid text, adding that the annotations contain words of wisdom that I wish could be made compulsory reading.


'/>"/>

Contact: Ingrid Benirschke
benirsch@cshl.edu
619-275-6021
Cold Spring Harbor Laboratory
Source:Eurekalert  

Page: 1

Related medicine news :

1. When couples face the diagnosis of cancer, women carry a larger emotional burden than men
2. Vitamin E Supplements May Raise Lung Cancer Risk
3. Certain vitamin supplements may increase lung cancer risk, especially in smokers
4. New study of targeted therapies for breast cancer -- model for global clinical trials
5. Broccoli Sprout Extract Hinders Bladder Cancer Development
6. Heart Hormones Beat Back Cancers in Mice
7. Cancer-related protein may play key role in Alzheimers disease
8. Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer
9. Atypical protein kinase C stabilizes SRC-3 levels in breast cancer cells
10. Breast cancer death rates among black women not decreasing across all states
11. Scientists Find Cancer Culprits in Cigarette Smoke
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer theory stands the test of time -- rediscovering Boveri a century later
(Date:5/28/2016)... ... May 28, 2016 , ... May 26, 2016- In ... Arts Fighting Challenge with theme event of “K Warriors” on June 4, 2016 at ... , The event is sponsored and hosted by Shaolin Institute and sanctioned by ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Two director-level employees ... YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen ... For this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... ... casual readers, this installment is bolstered by inspiring human-interest stories, courtesy of awareness-driven ... tech within the industry, from leading advocates, associations and industry leaders such as ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... students studying complementary medicine. Allison Outerbridge is this year’s Life University ... May 18 at the university’s Student Leadership Awards ceremony. , Outerbridge is approaching ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, ... respirators, according to court documents and SEC filings. A jury has returned ... v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 27, 2016 Kitov ... focused on late-stage drug development, today announced the ... of pivotal batches required for registration of KIT-302 ... This follows Kitov,s announcement in December ... met its primary efficacy endpoint. "We ...
(Date:5/26/2016)... 2016 TARE (Transarterial Radio-embolization) ... Savings and Overall Decreased Use of Hospital ... international specialist healthcare company, has today announced the ... Meeting of ISPOR (International Society for Pharmacoeconomics and ... (HCC) using yttrium-90 glass microspheres is associated with ...
(Date:5/25/2016)... HILDEN , Deutschland und GERMANTOWN, ... Zusammenarbeit mit Therawis bedient ... Entscheidungen bei Brustkrebs   QIAGEN N.V. ... QIA) gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung ... prädiktiver Assays für die Onkologie eingegangen zu sein. ...
Breaking Medicine Technology: